Clinical Trial Update: Doxycycline In Lymphangioleiomyomatosis (LAM) [Phase 4]

View source ↗

Summary

Phase 4 trial of doxycycline in lymphangioleiomyomatosis (LAM) has been completed, including cases associated with tuberous sclerosis complex.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphangioleiomyomatosis
• Tuberous Sclerosis Complex

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: University of Nottingham | Conditions: Lymphangioleiomyomatosis, Tuberous Sclerosis | Phase 4 | Status: COMPLETED